Related Experiment Videos
Thalidomide does not affect in vitro mixed skin cell lymphocyte reactions
Clinical and Experimental Dermatology
|January 1, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells.
International archives of allergy and immunology·1999
Internalization of gap junctions in benign familial pemphigus (Hailey-Hailey disease) and keratosis follicularis (Darier's disease).
The British journal of dermatology·1999
Human normal dermal fibroblasts express somatostatin receptors.
Experimental dermatology·1999
Gas chromatographic-mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution: method and clinical applications.
Journal of chromatography. B, Biomedical sciences and applications·1999
Presence of circulating abnormal CD34+ progenitors in adult Langerhans cell histiocytosis.
Clinical and experimental immunology·1999
Pendular motion in the brachiation of captive Lagothrix and Ateles.
American journal of primatology·1999
Acneiform Eruption with Deucravacitinib: Systematic Review and Meta-Analysis.
Clinical and experimental dermatology·2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.
Clinical and experimental dermatology·2026
The evolving understanding of prurigo nodularis.
Clinical and experimental dermatology·2026
Cutaneous inflammatory biomarkers in rosacea and their association with disease severity.
Clinical and experimental dermatology·2026
Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.
Clinical and experimental dermatology·2026
Short-term emicizumab in patients with acquired hemophilia A.
Haematologica·2026
Neglected intrahepatic foreign body following penetrating thoracoabdominal injury: a 10-month delayed presentation.
Journal of surgical case reports·2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed <i>FLT3</i>-ITD-negative acute myeloid leukemia.
Future oncology (London, England)·2026
Elevated nil values in TB-IGRA: a potential diagnostic clue for pediatric histiocytic necrotizing lymphadenitis.
Pediatric rheumatology online journal·2026